Sera Prognostics (SERA) Short term Debt (2020)
Sera Prognostics (SERA) reported Short term Debt of $4.4 million for Q4 2020.
Sera Prognostics (SERA) Short term Debt (2020) Analysis & Trends
Sera Prognostics has reported Short term Debt for 1 years, with the latest figure at $4.4 million in Q4 2020.
- For the quarter ending Q4 2020, Short term Debt changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2020 stood at $4.4 million (changed N/A YoY), and the FY2020 full-year result was $4.4 million, changed N/A from the prior year.
- Short term Debt for Q4 2020 stood at $4.4 million.
- The five-year high for Short term Debt was $4.4 million in Q4 2020, with the low at $4.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | Sera Prognostics | 111.57 Mn | 111.57 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.35 Mn |